Literature DB >> 24909887

Type I interferon protects antiviral CD8+ T cells from NK cell cytotoxicity.

Haifeng C Xu1, Melanie Grusdat2, Aleksandra A Pandyra3, Robin Polz2, Jun Huang2, Piyush Sharma3, René Deenen4, Karl Köhrer4, Ramtin Rahbar5, Andreas Diefenbach6, Kathrin Gibbert7, Max Löhning8, Lena Höcker9, Zoe Waibler9, Dieter Häussinger2, Tak W Mak5, Pamela S Ohashi5, Karl S Lang3, Philipp A Lang10.   

Abstract

Despite development of new antiviral drugs, viral infections are still a major health problem. The most potent antiviral defense mechanism is the innate production of type I interferon (IFN-I), which not only limits virus replication but also promotes antiviral T cell immunity through mechanisms, which remain insufficiently studied. Using the murine lymphocytic choriomeningitis virus model system, we show here that IFN-I signaling on T cells prevented their rapid elimination in vivo. Microarray analyses uncovered that IFN-I triggered the expression of selected inhibitory NK-cell-receptor ligands. Consequently, T cell immunity of IFN-I receptor (IFNAR)-deficient T cells could be restored by NK cell depletion or in NK-cell-deficient hosts (Nfil3(-/-)). The elimination of Ifnar1(-/-) T cells was dependent on NK-cell-mediated perforin expression. In summary, we identified IFN-I as a key player regulating the protection of T cells against regulatory NK cell function.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24909887     DOI: 10.1016/j.immuni.2014.05.004

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  113 in total

Review 1.  Boosting vaccine efficacy the natural (killer) way.

Authors:  Carolyn E Rydyznski; Stephen N Waggoner
Journal:  Trends Immunol       Date:  2015-08-10       Impact factor: 16.687

2.  The Inhibitory Receptor NKG2A Sustains Virus-Specific CD8⁺ T Cells in Response to a Lethal Poxvirus Infection.

Authors:  Aaron S Rapaport; Jill Schriewer; Susan Gilfillan; Ed Hembrador; Ryan Crump; Beatrice F Plougastel; Yaming Wang; Gaelle Le Friec; Jian Gao; Marina Cella; Hanspeter Pircher; Wayne M Yokoyama; R Mark L Buller; Marco Colonna
Journal:  Immunity       Date:  2015-12-08       Impact factor: 31.745

3.  Inactivation of Interferon Receptor Promotes the Establishment of Immune Privileged Tumor Microenvironment.

Authors:  Kanstantsin V Katlinski; Jun Gui; Yuliya V Katlinskaya; Angelíca Ortiz; Riddhita Chakraborty; Sabyasachi Bhattacharya; Christopher J Carbone; Daniel P Beiting; Melanie A Girondo; Amy R Peck; Ellen Puré; Priya Chatterji; Anil K Rustgi; J Alan Diehl; Constantinos Koumenis; Hallgeir Rui; Serge Y Fuchs
Journal:  Cancer Cell       Date:  2017-02-13       Impact factor: 31.743

4.  Antigen expression determines adenoviral vaccine potency independent of IFN and STING signaling.

Authors:  Kylie M Quinn; Daniel E Zak; Andreia Costa; Ayako Yamamoto; Kathrin Kastenmuller; Brenna J Hill; Geoffrey M Lynn; Patricia A Darrah; Ross W B Lindsay; Lingshu Wang; Cheng Cheng; Alfredo Nicosia; Antonella Folgori; Stefano Colloca; Riccardo Cortese; Emma Gostick; David A Price; Jason G D Gall; Mario Roederer; Alan Aderem; Robert A Seder
Journal:  J Clin Invest       Date:  2015-02-02       Impact factor: 14.808

Review 5.  Type I interferon: understanding its role in HIV pathogenesis and therapy.

Authors:  Steven E Bosinger; Netanya S Utay
Journal:  Curr HIV/AIDS Rep       Date:  2015-03       Impact factor: 5.071

Review 6.  Regulation of antiviral T cell responses by type I interferons.

Authors:  Josh Crouse; Ulrich Kalinke; Annette Oxenius
Journal:  Nat Rev Immunol       Date:  2015-03-20       Impact factor: 53.106

Review 7.  Type I interferon signaling, regulation and gene stimulation in chronic virus infection.

Authors:  Sabelo Lukhele; Giselle M Boukhaled; David G Brooks
Journal:  Semin Immunol       Date:  2019-05-30       Impact factor: 11.130

8.  Blockade of interferon Beta, but not interferon alpha, signaling controls persistent viral infection.

Authors:  Cherie T Ng; Brian M Sullivan; John R Teijaro; Andrew M Lee; Megan Welch; Stephanie Rice; Kathleen C F Sheehan; Robert D Schreiber; Michael B A Oldstone
Journal:  Cell Host Microbe       Date:  2015-05-13       Impact factor: 21.023

9.  Cutting Edge: STAT1-Mediated Epigenetic Control of Rsad2 Promotes Clonal Expansion of Antiviral NK Cells.

Authors:  Gabriela M Wiedemann; Clair D Geary; Colleen M Lau; Joseph C Sun
Journal:  J Immunol       Date:  2020-05-27       Impact factor: 5.422

Review 10.  Intrahepatic regulation of antiviral T cell responses at initial stages of viral infection.

Authors:  Yuejin Liang; Zakari Kwota; Jiaren Sun
Journal:  Int Immunopharmacol       Date:  2016-07-25       Impact factor: 4.932

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.